SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-20-087438
Filing Date
2020-07-28
Accepted
2020-07-28 17:29:16
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFBB3 LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm2025901d1_sc13da.htm SC 13D/A 118192
2 EXHIBIT 99.1 tm2025901d1_ex99-1.htm EX-99.1 52340
  Complete submission text file 0001104659-20-087438.txt   172293
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90491 | Film No.: 201054868
SIC: 2834 Pharmaceutical Preparations